Diane Delattre: SIU 46th Congress Highlights the Latest Advances in Uro-Oncology
Diane Delattre/ X

Diane Delattre: SIU 46th Congress Highlights the Latest Advances in Uro-Oncology

Diane Delattre, Global Medical Director Urology Oncology at Ferring Pharmaceuticals, shared SIU-Urology’s post on X, adding:

“Delighted to attend the SIU 46th Congress in Florence.

Looking forward to engaging with international experts and discussing advances in research and clinical practice.

An inspiring opportunity to strengthen scientific collaboration and discuss the latest innovations in uro-oncology.”

SIU-Urology shared:

“Florence is ready. The global urology community is here. Let SIU 2026 begin!

The excitement is building as urologists, researchers, innovators and industry partners from around the world come together for SIU 2026 in Florence!

Over the next four days, get ready to be inspired by groundbreaking research, emerging technologies, cutting-edge surgical techniques and thought-provoking discussions that will help shape the future of urology.

Learn. Connect. Share. Be inspired! 

Diane Delattre: SIU 46th Congress Highlights the Latest Advances in Uro-Oncology

We want to see SIU 2026 through YOUR eyes! Share your favourite moments, memorable sessions, new connections and Congress highlights. Tag SIU and join the conversation:

  • Facebook: SIUUrologyIntl
  • Instagram: siu_urology
  • LinkedIn: siu-urology
  • X: SIU_Urology

Not registered yet? There’s still time to join us in Florence or virtually.

Already registered? Make the most of your Congress experience with SIU.

Let’s make SIU 2026 four unforgettable days of learning, discovery and global connection!”

Other articles about genitourinary oncology on OncoDaily.

You can also read:

10 Must-Read Posts in GU Oncology This Week

Diane Delattre: SIU 46th Congress Highlights the Latest Advances in Uro-Oncology